Evidence map›Paper›PMID 42444145›Full record

ArticleJournal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics2026

Preexisting Fundus Findings in a Large Cohort of Young Cynomolgus Macaques (

T Michael Nork, Peter J Sonnentag, Paul E Miller, Hugh D Wabers, Carol A Rasmussen, Alexander W Katz, Charlene B Y Kim, James N Ver Hoeve, J Seth Eaton, Ellison Bentley and 4 more

Abstract read
In one paragraph

Article in Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

T Michael NorkDepartment of Ophthalmology and Visual Sciences, University of Wisconsin-Madison, Madison, Wisconsin, USA.ORCID 0000-0002-0687-373X
Peter J SonnentagLaboratory Corporation of America Holdings (Labcorp), Madison, Wisconsin, USA.
Paul E MillerOSOD, a Merit Company, Madison, Wisconsin, USA.
Hugh D WabersOSOD, a Merit Company, Madison, Wisconsin, USA.
Carol A RasmussenDepartment of Ophthalmology and Visual Sciences, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Alexander W KatzDepartment of Ophthalmology and Visual Sciences, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Charlene B Y KimDepartment of Ophthalmology and Visual Sciences, University of Wisconsin-Madison, Madison, Wisconsin, USA.
James N Ver HoeveDepartment of Ophthalmology and Visual Sciences, University of Wisconsin-Madison, Madison, Wisconsin, USA.
J Seth EatonOSOD, a Merit Company, Madison, Wisconsin, USA.
Ellison BentleyOSOD, a Merit Company, Madison, Wisconsin, USA.
Brian J ChristianOSOD, a Merit Company, Madison, Wisconsin, USA.
Charles A O'NeillOSOD, a Merit Company, Madison, Wisconsin, USA.
Craig E CrossonOSOD, a Merit Company, Madison, Wisconsin, USA.
Christopher J MurphyOSOD, a Merit Company, Madison, Wisconsin, USA.

Funding

UW Vision Research Core - Administrative CoreP30EY016665 · NEI · UNIVERSITY OF WISCONSIN-MADISON · PI AKIHIRO IKEDA · 2005 to 2026
$12.6M
NEI NIH HHS P30 EY016665
6 · The paper itself

Abstract

purposeTo categorize preexisting fundus findings in a large group of healthy young adult cynomolgus macaques [nonhuman primates (NHPs)] and to compare them to similar conditions in young human retinas.

methodsDuring the past 30 years, more than 20,000 young purpose-bred cynomolgus macaques were screened prior to enrollment in nonclinical pharmaceutical development studies at a single contract research organization. The fundus findings were documented by clinical examinations, various retinal imaging modalities, and/or visual electrophysiological testing.

resultsSheen from the internal limiting membrane (ILM) was common in these young adult NHPs as it is in young humans. Infrequent in both NHPs and humans were cilioretinal arteries. Small patches of retinal pigment epithelial (RPE) depigmentation were common, for which there is no human correlate. Likewise, there is no exact human correlate for foveal drusen-like spots in the young NHPs. Also common in NHPs but uncommon in humans were remnants of the fetal vasculature. Conditions rare in both NHPs and humans included myelinated nerve fiber layer, astrocytic hamartoma, coloboma, and congenital hypertrophy of the RPE. Notable rare abnormal findings included a white dot condition, a large macular tumor, and idiopathic optic atrophy, all of which were of unknown etiology. DISCUSSION: Preexisting abnormalities, when taken together, are common in NHPs and can occasionally complicate the assessment of toxicity from test articles subsequently administered, impacting the clinical development of test articles. As such, it is critical that NHPs be prescreened and, ideally, the fundus appearance be documented with fundus imaging when enrolled in preclinical studies.

Indexed as

electroretinography (ERG)fluorescein angiographyimagingpreclinical studiesretina

Identifiers

PMID42444145
PMCPMC13372212

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.